Skip to main content
Publications
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyaguez I, Brockbank J, Iglesias T, Llinares J, Sierra J. Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with Cd-33 positive acute myeloid leukaemia in Spain. Clinicoecon Outcomes Res. 2021 Apr 22;2021(13):263-77. doi: 10.2147/CEOR.S302097
Filippini T, Rothman KJ, Cocchio S, Narne E, Mantoan D, Saia M, Goffi A, Ferrari F, Maffeis G, Orsini N, Baldo V, Vinceti M. Associations between mortality from COVID-19 in two Italian regions and outdoor air pollution as assessed through tropospheric nitrogen dioxide. Sci Total Environ. 2021 Mar 15;760:143355. doi: 10.1016/j.scitotenv.2020.143355
Osorio-Yanez C, Clemente DBP, Maitre L, Vives-Usano M, Bustamante M, Martinez D, Casas M, Alexander J, Thomsen C, Chatzi L, Gutzkow KB, Grazuleviciene R, Martens DS, Plusquin M, Slama R, McEachan RC, Wright J, Yang TC, Urquiza J, Tamayo I, Sunyer J, Vafeiadi M, Nawrot TS, Vrijheid M. Early life tobacco exposure and children's telomere length: the HELIX project. Sci Total Environ. 2020 Apr;711:135028. doi: 10.1016/j.scitotenv.2019.135028
Cechova E, Scheringer M, Seifertova M, Mikes O, Kroupova K, Kuta J, Forns J, Eggesbo M, Quaak I, de Cock M, van de Bor M, Patayova H, Palkovicova Murinova L, Kocan A. Developmental neurotoxicants in human milk: comparison of levels and intakes in three European countries. Sci Total Environ. 2017 Feb 1;579:637-45. doi: 10.1016/j.scitotenv.2016.11.046
Arnold LM, Williams DA, Hudson JI, Martin SA, Clauw DJ, Crofford LJ, Wang F, Emir B, Lai C, Zablocki R, Mease PJ. Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum. 2012 Mar 1;64(3):885-94.